Publications by authors named "Shimon Ohtake"

Claim this Profile
C
Contemporary management of diffuse large B-cell lymphoma in Japan.
Katsuhiro Miura, Hiromichi Takahashi, Haruna Nishimaki-Watanabe, Takashi Hamada, Akihiro Uchiike, Shimon Ohtake

Expert Rev Anticancer Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers' polycythemia and polycythemia vera.
Kazuhide Iizuka, Yoshikazu Iizuka, Shun Ito, Toshihide Endo, Hironao Nukariya, Shimon Ohtake

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation.
Takashi Hamada, Hiromichi Takahashi, Masaru Nakagawa, Hironao Nukariya, Shun Ito, Shimon Ohtake

Case Rep Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.
Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Takashi Hamada, Yoshihito Uchino, Shimon Ohtake

Expert Rev Anticancer Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Shimon Ohtake, Hiromichi Takahashi, Masaru Nakagawa, Yoshihito Uchino, Katsuhiro Miura

J Infect Chemother· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effect of immunophenotyping on the prognosis of multiple myeloma patients treated with bortezomib.
Noriyoshi Iriyama, Katsuhiro Miura, Yoshihiro Hatta, Sumiko Kobayashi, Yoshihito Uchino, Shimon Ohtake

Oncol Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Katsuhiro Miura, Hiromichi Takahashi, Masaru Nakagawa, Asami Izu, Masahiko Sugitani, Shimon Ohtake

Leuk Lymphoma· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative impact of concurrent overexpression of MYC and BCL2 in patients with advanced diffuse large B-cell lymphoma treated with dose-intensified immunochemotherapy.
Hiromichi Takahashi, Katsuhiro Miura, Masaru Nakagawa, Masahiko Sugitani, Yusuke Amano, Shimon Ohtake

Leuk Lymphoma· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cyclin D1-negative mantle cell lymphoma with an IGL-CCND2 translocation that relapsed with blastoid morphology and aggressive clinical behavior.
Daisuke Kurita, Kengo Takeuchi, Sumiko Kobayashi, Atsuko Hojo, Yoshihito Uchino, Shimon Ohtake

Virchows Arch· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma cell maturity as a predictor of prognosis in multiple myeloma.
Noriyoshi Iriyama, Katsuhiro Miura, Yoshihiro Hatta, Yoshihito Uchino, Daisuke Kurita, Shimon Ohtake

Med Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies.
Katsuhiro Miura, Masaru Nakagawa, Hiromichi Takahashi, Yoshihito Uchino, Hitomi Kodaira, Shimon Ohtake

Int J Hematol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
Daisuke Kurita, Katsuhiro Miura, Masaru Nakagawa, Shimon Ohtake, Masashi Sakagami

Int J Hematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis